B-cell receptor pathway inhibitors affect CD20 levels and impair antitumor activity of anti-CD20 monoclonal antibodies
暂无分享,去创建一个
J. Gołąb | B. Pyrzyńska | P. Gaj | C. Fauriat | K. Giannopoulos | M. Dwojak | M. Bobrowicz | K. Bojarczuk | M. Siernicka | M. Winiarska | M. Karp | D. Efremov | B. Pyrzynska